Can a ‘miracle’ weight loss drug end Britain's obesity epidemic? [Replay]
The Story
00:00
Revolutionizing Diabetes: From Treatment to Weight Loss
This chapter explores the groundbreaking developments in diabetes treatments, particularly focusing on semaglutide, a synthetic hormone derived from lizard saliva. It examines the societal implications of its unexpected side effect of weight loss, notably its adoption by celebrities, and discusses the rising popularity of Novo Nordisk's drugs, Ozempic and Wegovy, in managing obesity. Through the lens of personal narratives and the company’s history, the chapter delves into the transformation of pharmaceutical approaches to weight management and diabetes care.
Transcript
Play full episode
